A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia (Q34476154)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia |
scientific article |
Statements
1 reference
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia (English)
1 reference
Nancy Olivieri
1 reference
Patricia Giardina
1 reference
Gritta Janka-Schaub
1 reference
Maria Domenica Cappellini
1 reference
Alan Cohen
1 reference
Antonio Piga
1 reference
Mohamed Bejaoui
1 reference
Silverio Perrotta
1 reference
Leyla Agaoglu
1 reference
Yesim Aydinok
1 reference
Antonis Kattamis
1 reference
Yurdanur Kilinc
1 reference
John Porter
1 reference
Marcello Capra
1 reference
Renzo Galanello
1 reference
Slaheddine Fattoum
1 reference
Guillermo Drelichman
1 reference
Carmelo Magnano
1 reference
Monica Verissimo
1 reference
Miranda Athanassiou-Metaxa
1 reference
Alexandra Kourakli-Symeonidis
1 reference
Thomas Coates
1 reference
Christiane Vermylen
1 reference
Isabelle Thuret
1 reference
Herbert Opitz
1 reference
Catherine Ressayre-Djaffer
1 reference
Peter Marks
1 reference
Daniele Alberti
1 reference
13 December 2005
1 reference
Identifiers
1 reference